SCHEMBL22033657

SCHEMBL22033657

CCCCC(O)CC(=O)OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
MAPK1 P28482 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CTSL P07711 1/20 0.48
CTSS P25774 1/20 0.48
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
SLC15A1 P46059 2/20 0.47
CETP P11597 3/20 0.44
CNR2 P34972 1/20 0.44
ABCB1 P08183 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
TRPA1 O75762 1/20 0.43
PTGES O14684 1/20 0.43
ALOX5 P09917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6369826 0.96 ALDH1A1 (0.49) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL20966571 0.94 GPR84 (0.51) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL6370572 0.94 GPR84 (0.51) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL22033713 0.94 GPR84 (0.51) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL15710472 0.94 GPR84 (0.51) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL6370981 0.94 GPR84 (0.51) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL31674543 0.94 GPR84 (0.51) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL8862339 0.91 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL18196797 0.91 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR
SCHEMBL22033629 0.87 ALDH1A1 (0.55) ALDH1A1MAPK1L3MBTL1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250074866-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2025-03-06 US disclosed
CN-119285480-A Modified amine lipids 英特利亚治疗股份有限公司 2025-01-10 CN disclosed
US-12077483-B2 Modified amine lipids INTELLIA THERAPEUTICS, INC. (US) 2024-09-03 US disclosed
US-20220119341-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2022-04-21 US disclosed
US-20220119341-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2022-04-21 US disclosed
EP-3891127-A1 MODIFIED AMINE LIPIDS Intellia Therapeutics, Inc. (US) 2021-10-13 EP disclosed
CN-113260607-A Modified amine lipids 英特利亚治疗股份有限公司 2021-08-13 CN disclosed
WO-2020118041-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. (US) 2020-06-11 WO disclosed
WO-2020118041-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. (US) 2020-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12077483-B2 Modified amine lipids PHOSPHO1, SGMS1, SGMS2 ALDH1A1 1817/4885MAPK1 3908/4885L3MBTL1 2107/4885
US-20220119341-A1 MODIFIED AMINE LIPIDS PHOSPHO1, SGMS1, SGMS2 ALDH1A1 1817/4885MAPK1 3908/4885L3MBTL1 2107/4885
US-20250074866-A1 MODIFIED AMINE LIPIDS PHOSPHO1, SGMS1, SGMS2 ALDH1A1 1817/4885MAPK1 3908/4885L3MBTL1 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.